A detailed history of Everett Harris & CO transactions in Baxter International Inc stock. As of the latest transaction made, Everett Harris & CO holds 550,579 shares of BAX stock, worth $16.1 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
550,579
Previous 563,908 2.36%
Holding current value
$16.1 Million
Previous $18.9 Million 10.83%
% of portfolio
0.26%
Previous 0.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$32.85 - $40.26 $437,857 - $536,625
-13,329 Reduced 2.36%
550,579 $20.9 Million
Q2 2024

Aug 01, 2024

SELL
$32.87 - $43.55 $127,634 - $169,104
-3,883 Reduced 0.68%
563,908 $18.9 Million
Q1 2024

Apr 19, 2024

SELL
$37.88 - $43.77 $166,596 - $192,500
-4,398 Reduced 0.77%
567,791 $24.3 Million
Q4 2023

Jan 18, 2024

SELL
$31.71 - $38.95 $1.07 Million - $1.31 Million
-33,665 Reduced 5.56%
572,189 $22.1 Million
Q3 2023

Oct 23, 2023

SELL
$37.32 - $49.29 $818,763 - $1.08 Million
-21,939 Reduced 3.49%
605,854 $22.9 Million
Q2 2023

Jul 26, 2023

SELL
$39.98 - $47.68 $5.06 Million - $6.04 Million
-126,639 Reduced 16.79%
627,793 $28.6 Million
Q1 2023

Apr 24, 2023

BUY
$37.58 - $52.57 $707,368 - $989,525
18,823 Added 2.56%
754,432 $30.6 Million
Q4 2022

Jan 20, 2023

BUY
$49.7 - $57.71 $394,667 - $458,275
7,941 Added 1.09%
735,609 $0
Q3 2022

Oct 21, 2022

BUY
$53.86 - $66.8 $3.53 Million - $4.37 Million
65,465 Added 9.89%
727,668 $39.2 Million
Q2 2022

Jul 22, 2022

SELL
$63.83 - $80.0 $84,957 - $106,480
-1,331 Reduced 0.2%
662,203 $42.5 Million
Q1 2022

Apr 22, 2022

BUY
$76.85 - $89.45 $601,812 - $700,482
7,831 Added 1.19%
663,534 $51.5 Million
Q4 2021

Feb 02, 2022

BUY
$74.57 - $87.19 $570,758 - $667,352
7,654 Added 1.18%
655,703 $56.3 Million
Q3 2021

Nov 03, 2021

BUY
$73.77 - $83.61 $123,195 - $139,628
1,670 Added 0.26%
648,049 $52.1 Million
Q2 2021

Jul 29, 2021

SELL
$80.5 - $88.01 $101,269 - $110,716
-1,258 Reduced 0.19%
646,379 $52 Million
Q1 2021

May 13, 2021

SELL
$76.38 - $86.03 $308,193 - $347,131
-4,035 Reduced 0.62%
647,637 $54.6 Million
Q4 2020

Feb 04, 2021

BUY
$75.39 - $82.36 $1.28 Million - $1.4 Million
17,016 Added 2.68%
651,672 $52.3 Million
Q3 2020

Nov 03, 2020

BUY
$78.33 - $90.73 $1.52 Million - $1.76 Million
19,419 Added 3.16%
634,656 $51 Million
Q2 2020

Jul 29, 2020

BUY
$78.66 - $94.14 $1.04 Million - $1.24 Million
13,161 Added 2.19%
615,237 $53 Million
Q1 2020

Apr 29, 2020

BUY
$71.57 - $93.3 $5.27 Million - $6.87 Million
73,620 Added 13.93%
602,076 $48.9 Million
Q4 2019

Jan 27, 2020

SELL
$76.7 - $88.45 $45,329 - $52,273
-591 Reduced 0.11%
528,456 $44.2 Million
Q3 2019

Nov 06, 2019

SELL
$81.4 - $89.78 $276,841 - $305,341
-3,401 Reduced 0.64%
529,047 $46.3 Million
Q2 2019

Aug 13, 2019

BUY
$73.44 - $82.41 $8,445 - $9,477
115 Added 0.02%
532,448 $43.6 Million
Q1 2019

May 13, 2019

SELL
$64.48 - $81.31 $1.76 Million - $2.22 Million
-27,284 Reduced 4.88%
532,333 $43.3 Million
Q4 2018

Feb 13, 2019

SELL
$61.45 - $77.8 $270,134 - $342,008
-4,396 Reduced 0.78%
559,617 $36.8 Million
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $43,274 - $47,583
-612 Reduced 0.11%
564,013 $43.5 Million
Q2 2018

Jul 27, 2018

SELL
$63.43 - $75.41 $125,527 - $149,236
-1,979 Reduced 0.35%
564,625 $41.7 Million
Q1 2018

Apr 20, 2018

BUY
$62.56 - $72.26 $4.25 Million - $4.91 Million
67,999 Added 13.64%
566,604 $36.9 Million
Q4 2017

Feb 01, 2018

SELL
$61.45 - $66.05 $43,383 - $46,631
-706 Reduced 0.14%
498,605 $32.2 Million
Q3 2017

Oct 11, 2017

BUY
$59.5 - $64.61 $29.7 Million - $32.3 Million
499,311
499,311 $31.3 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.